124 related articles for article (PubMed ID: 8476893)
1. Urodilatin, a new therapy to prevent kidney failure after heart transplantation.
Hummel M; Kuhn M; Bub A; Mann B; Schneider B; von Eickstedt KW; Forssmann WG; Hetzer R
J Heart Lung Transplant; 1993; 12(2):209-17; discussion 217-8. PubMed ID: 8476893
[TBL] [Abstract][Full Text] [Related]
2. Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients.
Hummel M; Kuhn M; Bub A; Bittner H; Kleefeld D; Marxen P; Schneider B; Hetzer R; Forssmann WG
Clin Investig; 1992 Aug; 70(8):674-82. PubMed ID: 1392444
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic use of low-dose urodilatin for prevention of renal impairment following liver transplantation: a randomized placebo-controlled study.
Langrehr JM; Kahl A; Meyer M; Neumann U; Knoop M; Jonas S; Steinmüller T; Bechstein WO; Frei U; Forssmann WG; Neuhaus P
Clin Transplant; 1997 Dec; 11(6):593-8. PubMed ID: 9408691
[TBL] [Abstract][Full Text] [Related]
4. Concomitant treatment with urodilatin (ularitide) does not improve renal function in patients with acute renal failure after major abdominal surgery--a randomized controlled trial.
Herbert MK; Ginzel S; Mühlschlegel S; Weis KH
Wien Klin Wochenschr; 1999 Feb; 111(4):141-7. PubMed ID: 10192146
[TBL] [Abstract][Full Text] [Related]
5. Significance of prophylactic urodilatin (INN: ularitide) infusion for the prevention of acute renal failure in patients after heart transplantation.
Brenner P; Meyer M; Reichenspurner H; Meiser B; Müller R; Mentz P; Schulz-Knappe P; Uberbacher HJ; Kreuzer E; Uberführ P
Eur J Med Res; 1995 Dec; 1(3):137-43. PubMed ID: 9389675
[TBL] [Abstract][Full Text] [Related]
6. Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide).
Wiebe K; Meyer M; Wahlers T; Zenker D; Schulze F; Michels P; Dalichau H; Mohr FW; Borst H; Forssmann WG
Eur J Med Res; 1996 Feb; 1(5):259-65. PubMed ID: 9374447
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of the natriuretic peptide ularitide in acute renal failure.
Meyer M; Pfarr E; Schirmer G; Uberbacher HJ; Schöpe K; Böhm E; Flüge T; Mentz P; Scigalla P; Forssmann WG
Ren Fail; 1999 Jan; 21(1):85-100. PubMed ID: 10048120
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute renal failure with urodilatin after unrelated bone marrow transplantation in an 18-month-old boy.
Laws HJ; Kropp S; Meyer M; Forssmann WG; Burdach S
Bone Marrow Transplant; 1995 Aug; 16(2):307-10. PubMed ID: 7581153
[TBL] [Abstract][Full Text] [Related]
9. Urodilatin, a natriuretic peptide with clinical implications.
Meyer M; Richter R; Forssmann WG
Eur J Med Res; 1998 Feb; 3(1-2):103-110. PubMed ID: 9512977
[TBL] [Abstract][Full Text] [Related]
10. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial.
Mitrovic V; Lüss H; Nitsche K; Forssmann K; Maronde E; Fricke K; Forssmann WG; Meyer M
Am Heart J; 2005 Dec; 150(6):1239. PubMed ID: 16338265
[TBL] [Abstract][Full Text] [Related]
11. [Urodilatin (INN: ularitide). A new peptide in the treatment of acute kidney failure following liver transplantation].
Kuse ER; Meyer M; Constantin R; Oldhafer K; Schlitt HJ; Schulz-Knappe P; Uberbacher HJ; Pichlmayr R; Forssmann WG
Anaesthesist; 1996 Apr; 45(4):351-8. PubMed ID: 8702053
[TBL] [Abstract][Full Text] [Related]
12. Potential renal protective benefits of intra-operative BNP infusion during cardiac transplantation.
Zierer A; Voeller RK; Melby SJ; Kawa CB; Guthrie TJ; Baumgartner M; Pasque MK; Moon MR; Moazami N
Transplant Proc; 2006 Dec; 38(10):3680-4. PubMed ID: 17175366
[TBL] [Abstract][Full Text] [Related]
13. The renal paracrine peptide system--possible urologic implications of urodilatin.
Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
[TBL] [Abstract][Full Text] [Related]
14. Renal effects of ularitide in patients with decompensated heart failure.
Lüss H; Mitrovic V; Seferovic PM; Simeunovic D; Ristić AD; Moiseyev VS; Forssmann WG; Hamdy AM; Meyer M
Am Heart J; 2008 Jun; 155(6):1012.e1-8. PubMed ID: 18513512
[TBL] [Abstract][Full Text] [Related]
15. Effect of 1-28 alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation.
Gianello P; Carlier M; Jamart J; Hulhoven R; Bernheim J; Bernard A; Ketelslegers JM; Squifflet JP
Clin Transplant; 1995 Dec; 9(6):481-9. PubMed ID: 8645892
[TBL] [Abstract][Full Text] [Related]
16. [Natriuretic peptides in the therapy of acute decompensated heart failure].
Gassanov N; Caglayan E; Erdmann E; Er F
Dtsch Med Wochenschr; 2011 Aug; 136(34-35):1738-43. PubMed ID: 21877307
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of added low-dose dopamine in acute heart failure patients with diuretic resistance to natriuretic peptide.
Kamiya M; Sato N; Nozaki A; Akiya M; Okazaki H; Takahashi Y; Mizuno K; Shimizu W
J Cardiovasc Pharmacol; 2015 Mar; 65(3):282-8. PubMed ID: 25748698
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of continuous urodilatin infusion: a dose-finding study.
Dorner GT; Selenko N; Kral T; Schmetterer L; Eichler HG; Wolzt M
Clin Pharmacol Ther; 1998 Sep; 64(3):322-30. PubMed ID: 9757156
[TBL] [Abstract][Full Text] [Related]
19. Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation.
Cedidi C; Meyer M; Kuse ER; Schulz-Knappe P; Ringe B; Frei U; Pichlmayr R; Forssmann WG
Eur J Clin Invest; 1994 Sep; 24(9):632-9. PubMed ID: 7828636
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
